Back to Search
CHRISTINA TYRRELL, PHARMD
PHARMD
Pharmacist
NPI: 1427458942Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
S020544(AZ)
Research & Publications (20)
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up.
PMID 17102802·Prostate Cancer Prostatic Dis·2007
2-rct
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.
PMID 17544845·Lancet Oncol·2007
3-trial
Recent trends in liver resection surgery activity and population utilization rates in English regions.
PMID 18345304·HPB (Oxford)·2007
8-other
Responses of Tuatara (Sphenodon punctatus) to removal of introduced Pacific rats from islands.
PMID 17650252·Conserv Biol·2007
7-preclinical
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration.
PMID 16771791·BJU Int·2006
4-observational
Non-suppression of testosterone in patients with a rising prostate-specific antigen level receiving luteinising hormone-releasing hormone analogues for metastatic prostate cancer.
PMID 16972347·Clin Oncol (R Coll Radiol)·2006
8-other
The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer.
PMID 16896884·J Cancer Res Clin Oncol·2006
4-observational
Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer.
PMID 15826748·Eur Urol·2005
3-trial
Re-utilization outcomes and costs of minor acute illness treated at family physician offices, walk-in clinics, and emergency departments.
PMID 16926958·Can Fam Physician·2005
4-observational
Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme.
PMID 16145740·Radiother Oncol·2005
4-observational
ACTH-induced stress response during pregnancy in a viviparous gecko: no observed effect on offspring quality.
PMID 16106406·J Exp Zool A Comp Exp Biol·2005
7-preclinical
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programme.
PMID 15931272·Prostate Cancer Prostatic Dis·2005
3-trial
Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs following injury: identification of alveolar intermediate cell types.
PMID 15849211·Am J Physiol Lung Cell Mol Physiol·2005
7-preclinical
Immediate Treatment with Bicalutamide, 150 mg/d, Following Radiotherapy in Localized or Locally Advanced Prostate Cancer.
PMID 16985858·Rev Urol·2004
8-other
Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia.
PMID 15380582·Int J Radiat Oncol Biol Phys·2004
3-trial
Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program.
PMID 15134983·Urology·2004
3-trial
Protecting embryos from stress: corticosterone effects and the corticosterone response to capture and confinement during pregnancy in a live-bearing lizard (Hoplodactylus maculatus).
PMID 14636639·Gen Comp Endocrinol·2003
7-preclinical
The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study.
PMID 12756493·World J Urol·2003
4-observational
Patient satisfaction and quality of care in walk-in clinics, family practices and emergency departments: the Ontario Walk-In Clinic Study.
PMID 12695380·CMAJ·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1825 W BELL RD
PHOENIX, AZ 85023 - Phone
- (602) 942-4764
Quick Facts
- NPI
- 1427458942
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile